Unexpected Favorable Outcome to PD-1 Antibody Plus Lenvatinib in a Patient With Recurrent Intestinal Follicular Dendritic Cell Sarcoma: A Case Report and Literature Review

BACKGROUND: Follicular dendritic cell sarcoma (FDCS) is an uncommon malignant cancer, and there is no standard treatment to date. Resection followed by adjuvant chemotherapy or radiation is considered the most commonly used strategy for treatment. However, the treatment for patients who have progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Yanna, Zhao, Sha, Jiang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456086/
https://www.ncbi.nlm.nih.gov/pubmed/34566950
http://dx.doi.org/10.3389/fimmu.2021.653319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456086/
https://www.ncbi.nlm.nih.gov/pubmed/34566950
http://dx.doi.org/10.3389/fimmu.2021.653319

Ejemplares similares